Condensed Consolidated Statements of Commitment to Issue Class A Common Stock and Stockholders’ Equity (Deficit) - USD ($) $ in Thousands		Total	Commitment To Issue Registered Shares	The9 Conditional Obligation	Related Party Notes Payable	Notes payable	Cumulative Effect, Period of Adoption, Adjustment	Class A Common Stock	Class A Common Stock Commitment To Issue Registered Shares	Class A Common Stock Cumulative Effect, Period of Adoption, Adjustment	Common Stock Class A Common Stock		Common Stock Class A Common Stock Commitment To Issue Registered Shares	Common Stock Class A Common Stock The9 Conditional Obligation	Common Stock Class A Common Stock Related Party Notes Payable	Common Stock Class A Common Stock Notes payable	Common Stock Class B Common Stock		Additional Paid-in Capital	Additional Paid-in Capital Commitment To Issue Registered Shares	Additional Paid-in Capital The9 Conditional Obligation	Additional Paid-in Capital Related Party Notes Payable	Additional Paid-in Capital Notes payable	Accumulated Other Comprehensive Gain (Loss)	Accumulated Deficit (As Restated)	Accumulated Deficit (As Restated) Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Dec. 31, 2020	[1]										93,099,596						64,000,588
Beginning balance at Dec. 31, 2020		$ (579,338)									$ 9						$ 6		$ 1,817,760					$ (5,974)	$ (2,391,139)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Transfer of private warrants to unaffiliated parties		0
Conversion of convertible securities (in shares)	[1]													423,053	22,454,776	7,688,153
Conversion of convertible securities				$ 2,863	$ 294,796	$ 98,375									$ 2	$ 1					$ 2,863	$ 294,794	$ 98,374
Issuance of Class A Common Stock in the Business Combination, net of transaction costs (in shares)	[1]										27,798,411
Issuance of Class A Common Stock in the Business Combination, net of transaction costs		170,114									$ 3								170,111
Conversion of assumed PSAC convertible and promissory notes payable into Class A Common Stock (in shares)	[1]										80,000
Conversion of assumed PSAC convertible and promissory notes payable into Class A Common Stock		790																	790
Conversion of liabilities into Class A Common Stock in the Business Combination (in shares)	[1]										20,666,825
Conversion of liabilities into Class A Common Stock in the Business Combination		285,337									$ 2								285,335
Conversion of liabilities into the commitment to issue Class A Common Stock in the Business Combination		52,338																	52,338
Legacy FF Ordinary Stock exchanged in the Business Combination for a commitment to issue Class A and Class B Common Stock (in shares)	[1]										(117,839,510)						(64,000,588)
Legacy FF Ordinary Stock exchanged in the Business Combination for a commitment to issue Class A and Class B Common Stock		0									$ (12)						$ (6)		18
Issuance of shares (in shares)	[1]										76,140,000
Issuance of shares		692,405									$ 8								692,397
Settlement of lawsuit with issuance of vested stock options		8,459																	8,459
Settlement of accrued rent with issuance of vested stock options		951																	951
Vesting of restricted stock award for employee bonus		14,620																	14,620
Stock-based compensation (as restated)		8,521																	8,521
Exercise of stock options (in shares)	[1]										4,326,920
Exercise of stock options		10,492																	10,492
Settlement of receivables through receipt of Class A Common Stock (in shares)	[1]										(43,096)
Settlement of receivables through receipt of Class A Common Stock		(105)																	(105)
Issuance of warrants		17,596																	17,596
Foreign currency translation adjustment		(487)																						(487)
Net loss		(432,206)																							(432,206)
Ending balance (in shares) at Sep. 30, 2021											134,795,128	[1]					0	[2]
Ending balance at Sep. 30, 2021		645,521									$ 13						$ 0		3,475,314					(6,461)	(2,823,345)
Beginning balance (in shares) at Jun. 30, 2021	[2]										107,659,654						64,000,588
Beginning balance at Jun. 30, 2021		(552,759)									$ 10						$ 6		1,973,314					(6,650)	(2,519,439)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of convertible securities (in shares)	[2]														11,566,196	7,688,153
Conversion of convertible securities					$ 160,437	$ 98,375									$ 1	$ 1						$ 160,436	$ 98,374
Issuance of Class A Common Stock in the Business Combination, net of transaction costs (in shares)	[2]										27,798,411
Issuance of Class A Common Stock in the Business Combination, net of transaction costs		170,114									$ 3								170,111
Conversion of assumed PSAC convertible and promissory notes payable into Class A Common Stock (in shares)	[2]										80,000
Conversion of assumed PSAC convertible and promissory notes payable into Class A Common Stock		790																	790
Conversion of liabilities into Class A Common Stock in the Business Combination (in shares)	[2]										20,666,825
Conversion of liabilities into Class A Common Stock in the Business Combination		285,337									$ 2								285,335
Conversion of liabilities into the commitment to issue Class A Common Stock in the Business Combination		52,338																	52,338
Legacy FF Ordinary Stock exchanged in the Business Combination for a commitment to issue Class A and Class B Common Stock (in shares)	[2]										(117,839,510)						(64,000,588)
Legacy FF Ordinary Stock exchanged in the Business Combination for a commitment to issue Class A and Class B Common Stock		0									$ (12)						$ (6)		18
Issuance of shares (in shares)	[2]										76,140,000
Issuance of shares		692,405									$ 8								692,397
Settlement of lawsuit with issuance of vested stock options		8,459																	8,459
Settlement of accrued rent with issuance of vested stock options		951																	951
Vesting of restricted stock award for employee bonus		14,620																	14,620
Stock-based compensation (as restated)		5,053																	5,053
Exercise of stock options (in shares)	[2]										1,078,495
Exercise of stock options		2,740																	2,740
Settlement of receivables through receipt of Class A Common Stock (in shares)	[2]										(43,096)
Settlement of receivables through receipt of Class A Common Stock		(105)																	(105)
Issuance of warrants		10,483																	10,483
Foreign currency translation adjustment		189																						189
Net loss		(303,906)																							(303,906)
Ending balance (in shares) at Sep. 30, 2021											134,795,128	[1]					0	[2]
Ending balance at Sep. 30, 2021		645,521									$ 13						$ 0		3,475,314					(6,461)	(2,823,345)
Beginning balance (in shares) at Dec. 31, 2021								0
Beginning balance at Dec. 31, 2021								$ 0
Beginning balance (Accounting Standards Update 2020-06) at Dec. 31, 2021										$ 32,900
Increase (Decrease) in Temporary Equity [Roll Forward]
Issuance pursuant to commitment to issue registered shares									$ (32,900)
Ending balance (in shares) at Sep. 30, 2022								0
Ending balance at Sep. 30, 2022								$ 0
Beginning balance (in shares) at Dec. 31, 2021											168,693,323						0
Beginning balance at Dec. 31, 2021		567,654									$ 17						$ 0		3,482,226					(6,945)	(2,907,644)
Beginning balance (Accounting Standards Update 2020-06) at Dec. 31, 2021							$ (20,265)																			$ (20,265)
Beginning balance (Accounting Standards Update 2016-02) at Dec. 31, 2021							$ 3,393																			$ 3,393
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Transfer of private warrants to unaffiliated parties		186																	186
Amendment of ATW NPA Warrants (Note 13)		1,238																	1,238
Conversion of convertible securities (in shares)											64,843,850
Conversion of convertible securities		84,780									$ 6								84,774
Issuance of shares (in shares)											89,152,131		2,387,500				64,000,588
Issuance of shares		0	$ 32,900								$ 7						$ 6		(13)	$ 32,900
Stock-based compensation (as restated)		9,144																	9,144
Exercise of stock options (in shares)											4,100,008
Exercise of stock options		9,535																	9,535
Settlement of receivables through receipt of Class A Common Stock (in shares)											(96,759)
Settlement of receivables through receipt of Class A Common Stock		(767)																	(767)
Receipt of class A common stock in consideration of exercises of options (in shares)											(311,878)
Receipt of class A common stock in consideration of exercises of options		(669)																	(669)
Exercise of warrants (in shares)											17,026,193
Exercise of warrants		1,728									$ 1								1,727
Foreign currency translation adjustment		13,548																						13,548
Net loss		(414,664)																							(414,664)
Ending balance (in shares) at Sep. 30, 2022											345,794,368						64,000,588
Ending balance at Sep. 30, 2022		287,741									$ 31						$ 6		3,620,281					6,603	(3,339,180)
Beginning balance (in shares) at Jun. 30, 2022								0
Beginning balance at Jun. 30, 2022								$ 32,900
Increase (Decrease) in Temporary Equity [Roll Forward]
Issuance pursuant to commitment to issue registered shares									$ (32,900)
Ending balance (in shares) at Sep. 30, 2022								0
Ending balance at Sep. 30, 2022								$ 0
Beginning balance (in shares) at Jun. 30, 2022											238,543,475						64,000,588
Beginning balance at Jun. 30, 2022		268,502									$ 24						$ 6		3,491,041					(3,261)	(3,219,308)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Transfer of private warrants to unaffiliated parties		186																	186
Amendment of ATW NPA Warrants (Note 13)		1,238																	1,238
Conversion of convertible securities (in shares)											64,843,850
Conversion of convertible securities		84,780									$ 6								84,774
Issuance of shares (in shares)								20,264,715			20,264,715		2,387,500
Issuance of shares			$ 32,900																	$ 32,900
Stock-based compensation (as restated)		2,670																	2,670
Exercise of stock options (in shares)											3,137,272
Exercise of stock options		7,181																	7,181
Settlement of receivables through receipt of Class A Common Stock (in shares)											(96,759)
Settlement of receivables through receipt of Class A Common Stock		(767)																	(767)
Receipt of class A common stock in consideration of exercises of options (in shares)											(311,878)
Receipt of class A common stock in consideration of exercises of options		(669)																	(669)
Exercise of warrants (in shares)											17,026,193
Exercise of warrants		1,728									$ 1								1,727
Foreign currency translation adjustment		9,864																						9,864
Net loss		(119,872)																							(119,872)
Ending balance (in shares) at Sep. 30, 2022											345,794,368						64,000,588
Ending balance at Sep. 30, 2022		$ 287,741									$ 31						$ 6		$ 3,620,281					$ 6,603	$ (3,339,180)

[1] The shares of the Company’s common stock prior to the Business Combination (as defined in Note 1) have been retrospectively recast to reflect the change in the capital structure as a result of the Business Combination as described in Note 4.

[2] The shares of the Company’s common stock prior to the Business Combination (as defined in Note 1) have been retrospectively recast to reflect the change in the capital structure as a result of the Business Combination as described in Note 4.